• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AHSA1 在泛癌中的预后和免疫治疗意义及其与肝癌增殖和转移的关系。

The Prognostic and Immunotherapeutic Significance of AHSA1 in Pan-Cancer, and Its Relationship With the Proliferation and Metastasis of Hepatocellular Carcinoma.

机构信息

Reproductive Medicine Center, Yue Bei People's Hospital, Shantou University Medical College, Shaoguan, China.

Medical Research Center, Yue Bei People's Hospital, Shantou University Medical College, Shaoguan, China.

出版信息

Front Immunol. 2022 Jun 10;13:845585. doi: 10.3389/fimmu.2022.845585. eCollection 2022.

DOI:10.3389/fimmu.2022.845585
PMID:35757728
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9226343/
Abstract

The is a main activator of ATPase of Hsp90. Hsp90 is involved in various metabolic and developmental processes of tumor cells. Although, the role of in tumor cells is still unrecognized. In the current research, the RNA-seq of 33 tumors were downloaded using The Cancer Genome Atlas (TCGA) database for the analysis of expression in tumors. The Kaplan-Meier method was used for the evaluation of the prognostic significance of in patients with pan-cancer. Additionally, the correlation between and immune cell infiltration, immune checkpoint, pyroptosis-related molecules, epithelial cell transformation-related molecules, and autophagy-related molecules were analyzed by co-expression. Furthermore, we examined the effect of knockdown on cell function in Huh7 and HCCLM3 cells of hepatocellular carcinoma (HCC) cell lines. According to the finding of this study, up-regulation of expression was observed in numerous tumor tissues, and its over-expression in liver hepatocellular carcinoma (LIHC), lung adenocarcinoma (LUAD), and esophageal carcinoma (ESCA) could affect the overall survival and disease-specific survival of the patients. Meanwhile, as per the correlation analysis the expression of was greatly correlated with the expression of various immune cell infiltrates, immune checkpoint inhibitors, tumor mutation load, and microsatellite instability. Moreover, this study focused on analyzing the association of expression with multiple pathological stages in HCC, and confirmed that was an independent prognostic factor of HCC by univariate and multivariate COX regression in TCGA and The International Cancer Genome Consortium (ICGC) cohorts. At the same time, cellular experiments proved that the knockdown could decrease the proliferation activity, cell migration and invasion ability of HCC cells. Therefore, the results of this study indicated that can be used as a potential prognostic biomarker of tumors and it may have a significant role in the proliferation as well as migration of HCC cells.

摘要

该 是 Hsp90 的 ATPase 的主要激活剂。Hsp90 参与肿瘤细胞的各种代谢和发育过程。尽管如此,该 在肿瘤细胞中的作用仍未被识别。在目前的研究中,通过使用癌症基因组图谱 (TCGA) 数据库下载了 33 个肿瘤的 RNA-seq,以分析肿瘤中 的表达。Kaplan-Meier 方法用于评估 在泛癌患者中的预后意义。此外,通过共表达分析了 与免疫细胞浸润、免疫检查点、焦亡相关分子、上皮细胞转化相关分子和自噬相关分子的相关性。此外,我们还研究了敲低 在肝癌细胞系 Huh7 和 HCCLM3 细胞中的细胞功能的影响。根据本研究的结果,观察到许多肿瘤组织中 的表达上调,其在肝肝细胞癌 (LIHC)、肺腺癌 (LUAD) 和食管癌 (ESCA) 中的过表达会影响患者的总生存率和疾病特异性生存率。同时,根据相关性分析, 的表达与各种免疫细胞浸润、免疫检查点抑制剂、肿瘤突变负荷和微卫星不稳定性的表达密切相关。此外,本研究重点分析了 在 HCC 多个病理分期中的表达与多种病理分期的相关性,并通过 TCGA 和国际癌症基因组联盟 (ICGC) 队列的单因素和多因素 COX 回归证实, 在 HCC 中是独立的预后因素。同时,细胞实验证明,敲低 可以降低 HCC 细胞的增殖活性、细胞迁移和侵袭能力。因此,本研究的结果表明, 可以作为肿瘤的潜在预后生物标志物,并且可能在 HCC 细胞的增殖和迁移中发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4669/9226343/62d474ffe324/fimmu-13-845585-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4669/9226343/f5ecc63618c7/fimmu-13-845585-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4669/9226343/61a8809c4e5f/fimmu-13-845585-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4669/9226343/b6524a30782e/fimmu-13-845585-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4669/9226343/3fdd522859cd/fimmu-13-845585-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4669/9226343/38e8392aefde/fimmu-13-845585-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4669/9226343/6911e774aa7a/fimmu-13-845585-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4669/9226343/b2a8fc362d1c/fimmu-13-845585-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4669/9226343/ecb48d7709bb/fimmu-13-845585-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4669/9226343/62d474ffe324/fimmu-13-845585-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4669/9226343/f5ecc63618c7/fimmu-13-845585-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4669/9226343/61a8809c4e5f/fimmu-13-845585-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4669/9226343/b6524a30782e/fimmu-13-845585-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4669/9226343/3fdd522859cd/fimmu-13-845585-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4669/9226343/38e8392aefde/fimmu-13-845585-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4669/9226343/6911e774aa7a/fimmu-13-845585-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4669/9226343/b2a8fc362d1c/fimmu-13-845585-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4669/9226343/ecb48d7709bb/fimmu-13-845585-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4669/9226343/62d474ffe324/fimmu-13-845585-g009.jpg

相似文献

1
The Prognostic and Immunotherapeutic Significance of AHSA1 in Pan-Cancer, and Its Relationship With the Proliferation and Metastasis of Hepatocellular Carcinoma.AHSA1 在泛癌中的预后和免疫治疗意义及其与肝癌增殖和转移的关系。
Front Immunol. 2022 Jun 10;13:845585. doi: 10.3389/fimmu.2022.845585. eCollection 2022.
2
AHSA1 Regulates Hepatocellular Carcinoma Progression via the TGF-β/Akt-Cyclin D1/CDK6 Pathway.AHSA1通过TGF-β/Akt-细胞周期蛋白D1/细胞周期蛋白依赖性激酶6信号通路调节肝细胞癌进展。
J Hepatocell Carcinoma. 2023 Nov 8;10:2021-2036. doi: 10.2147/JHC.S407680. eCollection 2023.
3
N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma.N6-甲基腺苷(m6A)RNA 甲基化调节剂 SNRPC 是一种预后生物标志物,与肝癌的免疫治疗相关。
World J Surg Oncol. 2021 Aug 13;19(1):241. doi: 10.1186/s12957-021-02354-8.
4
Systematic analysis of the role of LDHs subtype in pan-cancer demonstrates the importance of LDHD in the prognosis of hepatocellular carcinoma patients.系统分析 LDHs 亚型在泛癌中的作用表明 LDHD 在肝细胞癌患者预后中的重要性。
BMC Cancer. 2024 Jan 31;24(1):156. doi: 10.1186/s12885-024-11920-8.
5
A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.泛癌种中肌动蛋白相关蛋白 2/3 复合物亚基 5 的全面预后和免疫分析及在肝细胞癌中的鉴定。
Front Immunol. 2022 Sep 6;13:944898. doi: 10.3389/fimmu.2022.944898. eCollection 2022.
6
RAC1 serves as a prognostic factor and correlated with immune infiltration in liver hepatocellular carcinoma.RAC1 可作为预后因素,并与肝癌的免疫浸润相关。
J Cancer Res Clin Oncol. 2024 Sep 12;150(9):418. doi: 10.1007/s00432-024-05933-w.
7
The prognostic value of RHBDF2 in Pan-Cancer, and its correlation with cell Adhesion of Hepatocellular Carcinoma.RHBDF2 在泛癌症中的预后价值及其与肝癌细胞黏附的相关性。
Biotechnol Genet Eng Rev. 2024 Oct;40(2):1024-1048. doi: 10.1080/02648725.2023.2191092. Epub 2023 Mar 21.
8
Pan-cancer analysis suggests histocompatibility minor 13 is an unfavorable prognostic biomarker promoting cell proliferation, migration, and invasion in hepatocellular carcinoma.泛癌分析表明,组织相容性微小13是一种不良预后生物标志物,可促进肝细胞癌中的细胞增殖、迁移和侵袭。
Front Pharmacol. 2022 Aug 15;13:950156. doi: 10.3389/fphar.2022.950156. eCollection 2022.
9
Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.泛癌分析 PARP1 改变作为预测免疫治疗效果的生物标志物及其表达水平与免疫治疗特征的关联。
Front Immunol. 2021 Aug 31;12:721030. doi: 10.3389/fimmu.2021.721030. eCollection 2021.
10
A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis.基于免疫基因组图谱分析的肝细胞癌新型预后指标
J Cell Physiol. 2021 Apr;236(4):2572-2591. doi: 10.1002/jcp.30015. Epub 2020 Aug 27.

引用本文的文献

1
Pan-cancer analysis reveals SGO1 as a potential cancer prognostic and immunological biomarker.泛癌分析揭示SGO1作为一种潜在的癌症预后和免疫生物标志物。
J Cancer. 2025 Jul 24;16(11):3372-3388. doi: 10.7150/jca.115334. eCollection 2025.
2
Differentially expressed ncRNAs as key regulators in infection of human bronchial epithelial cells by the SARS-CoV-2 Delta variant.差异表达的非编码RNA作为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变异株感染人支气管上皮细胞的关键调节因子
Mol Ther Nucleic Acids. 2025 May 14;36(2):102559. doi: 10.1016/j.omtn.2025.102559. eCollection 2025 Jun 10.
3
Bulk and single-cell RNA sequencing identify prognostic signatures related to FGFBP2 NK cell in hepatocellular carcinoma.

本文引用的文献

1
A Comprehensive Prognostic and Immune Analysis of SLC41A3 in Pan-Cancer.全癌中SLC41A3的综合预后及免疫分析
Front Oncol. 2021 Jan 14;10:586414. doi: 10.3389/fonc.2020.586414. eCollection 2020.
2
A pan-cancer analysis of the human tumor coagulome and its link to the tumor immune microenvironment.人类肿瘤凝血组的泛癌分析及其与肿瘤免疫微环境的联系。
Cancer Immunol Immunother. 2021 Apr;70(4):923-933. doi: 10.1007/s00262-020-02739-w. Epub 2020 Oct 15.
3
Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment.
批量和单细胞RNA测序鉴定出与肝细胞癌中FGFBP2自然杀伤细胞相关的预后特征。
PeerJ. 2025 May 20;13:e19337. doi: 10.7717/peerj.19337. eCollection 2025.
4
Expression, prognosis and preliminary investigation of the mechanism of action of ACTR6, a member of the ARPs gene family, in hepatocellular carcinoma.ARP基因家族成员ACTR6在肝细胞癌中的表达、预后及作用机制的初步研究
Front Med (Lausanne). 2025 Mar 10;12:1513233. doi: 10.3389/fmed.2025.1513233. eCollection 2025.
5
Pan-cancer and multi-omics analysis: NDUFA1 is a potential therapeutic target and prognostic marker for esophageal cancer.泛癌和多组学分析:NDUFA1是食管癌的潜在治疗靶点和预后标志物。
Cell Biol Toxicol. 2025 Feb 12;41(1):43. doi: 10.1007/s10565-025-09993-7.
6
The role of Aha1 in cancer and neurodegeneration.Aha1在癌症和神经退行性疾病中的作用。
Front Mol Neurosci. 2024 Dec 24;17:1509280. doi: 10.3389/fnmol.2024.1509280. eCollection 2024.
7
A Six-Gene Signature Related to Liquid-Liquid Phase Separation for Diagnosis of Alzheimer's Disease.一种与液-液相分离相关的六基因特征用于阿尔茨海默病的诊断
Actas Esp Psiquiatr. 2024 Dec;52(6):759-768. doi: 10.62641/aep.v52i6.1762.
8
The prognostic value of immune escape-related genes in lung adenocarcinoma.免疫逃逸相关基因在肺腺癌中的预后价值
Transl Cancer Res. 2024 Jun 30;13(6):2647-2661. doi: 10.21037/tcr-23-2295. Epub 2024 Jun 25.
9
Analysis of the Anticancer Mechanism of OR3 Pigment from Streptomyces coelicolor JUACT03 Against the Human Hepatoma Cell Line Using a Proteomic Approach.采用蛋白质组学方法分析深绿链霉菌 JUACT03 中 OR3 色素对人肝癌细胞系的抗癌机制。
Cell Biochem Biophys. 2024 Jun;82(2):1061-1077. doi: 10.1007/s12013-024-01258-0. Epub 2024 Apr 5.
10
Research progress on molecular mechanism of pyroptosis caused by in gastric cancer.胃癌中[具体因素]引起细胞焦亡的分子机制研究进展 (你原文中“by”后面缺少具体内容)
Ann Med Surg (Lond). 2024 Feb 15;86(4):2016-2022. doi: 10.1097/MS9.0000000000001802. eCollection 2024 Apr.
重新定义肿瘤微环境中的肿瘤相关巨噬细胞亚群和功能。
Front Immunol. 2020 Aug 4;11:1731. doi: 10.3389/fimmu.2020.01731. eCollection 2020.
4
Progress in cancer mortality, incidence, and survival: a global overview.癌症死亡率、发病率及生存率的进展:全球概述
Eur J Cancer Prev. 2020 Sep;29(5):367-381. doi: 10.1097/CEJ.0000000000000594.
5
The cancer-natural killer cell immunity cycle.癌症-自然杀伤细胞免疫周期。
Nat Rev Cancer. 2020 Aug;20(8):437-454. doi: 10.1038/s41568-020-0272-z. Epub 2020 Jun 24.
6
MSI as a predictive factor for treatment outcome of gastroesophageal adenocarcinoma.微卫星不稳定性作为胃食管腺癌治疗结果的预测因素。
Cancer Treat Rev. 2020 Jun;86:102024. doi: 10.1016/j.ctrv.2020.102024. Epub 2020 Apr 28.
7
Metabolic Regulation of Macrophage Polarization in Cancer.癌症中巨噬细胞极化的代谢调控
Trends Cancer. 2019 Dec;5(12):822-834. doi: 10.1016/j.trecan.2019.10.007. Epub 2019 Nov 6.
8
PDIA4: The basic characteristics, functions and its potential connection with cancer.PDIA4:基本特征、功能及其与癌症的潜在联系。
Biomed Pharmacother. 2020 Feb;122:109688. doi: 10.1016/j.biopha.2019.109688. Epub 2019 Nov 30.
9
Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy.肿瘤微环境中的免疫细胞:在癌症免疫治疗中的生物学功能和作用。
Cancer Lett. 2020 Feb 1;470:126-133. doi: 10.1016/j.canlet.2019.11.009. Epub 2019 Nov 12.
10
Pyroptosis: A new frontier in cancer.细胞焦亡:癌症研究的新前沿。
Biomed Pharmacother. 2020 Jan;121:109595. doi: 10.1016/j.biopha.2019.109595. Epub 2019 Nov 9.